Delivery Order SPE2DB24D2216-SPE2DB25FGNLQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,500.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The contract is set for ultimate completion by April 25, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $1,479.44 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. This competitive award carries a ceiling value of $2,436.12 with firm fixed pricing and is scheduled for completion by July 21, 2025. The contract was not designated as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count) with a contract value of $2,307.76. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) with a ceiling value of $2,358.46. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $9,456.85. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract's ultimate completion date is September 12, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) under a firm fixed-price contract valued at $2,729.30. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,073.04 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count units). This order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $3,150.33. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the federal pharmaceutical procurement process. The order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,307.87. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGNLQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count) with a ceiling value of $1,346.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on April 25, 2025, and performance will occur at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves military and veteran healthcare systems through this comprehensive global pharmaceutical support vehicle. The company's extensive contract portfolio with DLA covers a wide range of medications across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with both brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/24/25 |